Title: Multiple Plexiform Neurofibromas in Neurofibromatosis Type 1: A Case Report

Authors: Dr Meena Chauhan, Dr G R Tegta, Dr Renu Rattan, Dr G K Verma

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i2.04

Abstract

Plexiform neurofibromas represent an uncommon variant (30%) of neurofibromatosis type 1 (NF-1). They account for substantial morbidity including disfigurement, functional impairment and may even be life threatening. More than one plexiform neurofibromas are uncommon in an individual of NF-1. We herewith, report a case of 50 years old female with NF 1 with multiple large plexiform neurofibromas over back, abdomen and left leg that began in early adulthood. Diagnosis of plexiform neurofibromas is usually made clinically, especially if classical signs of NF-1 are present. More than two diagnostic criteria for NF-1 were met, however in our case, the patient did not accept to undergo investigative work up and surgical resection and preferred to undergo clinical follow-up every 6 months. The current mainstay of the treatment of plexiform neurofibromas is surgical resection than medical therapy.

Keywords: Plexiform neurofibromas, Neurofibromatosis type 1, café-au-lait macules.

References

  1. Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A.2010; 152A(2):327–32. 
  2. Al-Otibi M, Rutka JT. Neurosurgical implications of neurofibromatosis type I in children. Neurosurg Focus. 2006;19 (6):E2  
  3. Levy Bencheton A, Mallet S, Rojat Habib MC, Figarella-Branger D, Sigaudy S, Grob JJ, et al. Isolated late-onset plexiform neurofibroma in the absence of neurofibromatosis. Ann Dermatol Venereol. 2010;(137):301–04. 
  4. Marocchio LS, Oliveira DT, Pereira MC, Soares CT, Fleury RN. Sporadic and multiple neurofibromas in the head and neck region: a retrospective study of 33 years. Clin Oral Investig. 2007;(11):165–69.
  5. Cebesoy O, Tutar E, Isik M, Arpacioglu O. A case of isolated giant plexiform neurofibroma involving all branches of the common peroneal nerve. Arch Orthop Trauma Surg. 2007;(127):709–12. 
  6. Lange F, Herlin C, Frison L, Bessis D, Rouleau-Dubois C, Bigorre M, et al. Management of plexiform neurofibroma isolated in childhood: About four observations. Ann Chir Plast Esthet. 2013;(58):694–99. 
  7. Neurofibromatosis. NIH Consens Statement1987; Jul 13-15;6(12):1–19.
  8. Needle MN, Cnaan A, Dattilo J, Chatten J, Phillips PC, Shochat S et al. Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974–1994. J Pediatr1997; (131):678–82. 
  9. Citak EC, Oguz A, Karadeniz C, Okur A, Memis L, Boyunaga O et al. Management of plexiform neurofibroma with interferon alpha. Pediatr Hematol Oncol. 2008; (25):673–78.
  10. Kebudi R, Cakir FB, Gorgun O.  Interferon-α for unresectable progressive and symptomatic plexiform neurofibromas J Pediatr Hematol Oncol. 2013; (35):115–17.

Corresponding Author

Dr Meena Chauhan

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile No 09816155876